廣東話、普通話和英語

中文和英文

中醫學、腎臟病學、代謝障礙性疾病、循證醫學

香港大學中醫藥學院助理教授，香港註冊中醫師，從事中醫藥教學、科研及臨床服務工作。擔任Frontiers in Physiology雜誌副編輯, Integrative Medicine in Nephrology and Andrology編委。擔任香港大學深圳醫院倫理審核委員會委員。

主要從事急慢性腎臟疾病及代謝障礙性疾病的分子機制及防治研究；促進中醫藥的循證醫學研究。主要方向：

• (1) 探索各類腎臟病及代謝障礙性疾病的發病機制（基因、蛋白、信號通路及免疫調節）；
• (2) 開發防治腎臟病及代謝疾病的轉化研究（如基因療法、中藥及活性成分）；
• (3) 開展中醫藥（針灸、中藥）循證醫學研究（系統評價及臨床試驗）

主持GRF、HMRF、中醫藥發展基金等7項，包括腎臟病的機制研究、針灸對於各類痛症（膝關節炎、媽媽手、膀胱過度活躍）及終末期腫瘤患者輔助療效的臨床隨機對照試驗及中醫藥對於COVID-19的循證醫學研究，共發表各類中英文學術論文近百篇。

為中醫藥學院本科生及研究生授課，同時也為護理學院及藥學系本科生授課，授課科目如下：

• BCHM1601 Foundation Theories of Chinese Medicine (中醫基礎理論)
• BCHM1602 Diagnostics of Chinese Medicine (中醫診斷學)
• BCHM1901 Introduction to Chinese Medical Cultures (中醫文化導讀)
• BCHM3801 Introduction to Chinese Medicine and Nursing
• BPHM4152 Chinese Medicine for Pharmacy Students
• BCHM4601 Treatise on Exogenous Febrile Diseases (傷寒論)
• MCHM6100 Research Methodology in Chinese Medicine (中醫科研思路與方法)
• MCHM6302 Classic Literature of Chinese Medicine (中醫經典原著研究)
• MCHM6501 Evidence-based Medicine (循證醫學)

慢性腎臟病及泌尿系疾病（含蛋白尿、尿頻/失禁、癃閉、男子弱精不育）、代謝障礙性疾病（糖尿病、高血壓、痛風、高血脂等）、情志疾病

學術學會：

• 1. 中國生理學會腎臟病專業委員會會員
• 2. 世界中醫藥聯合會,中醫藥安全委員會理事
• 3. 中醫藥規範研究學會會員

學術期刊編輯：

• 1. Frontiers in Physiology副編輯
• 2. Integrative Medicine in Nephrology and Andrology編委

1. Leung K*, Ma OC*, Qin Z*, Ting H, Lau AH, Lun KK, Chan HY, Wen GY, Ng JT, Chow L, Chu CY, Ho TS, Tsang K, Ng BFL, Fok MWM, Fang CXS, Lao L, Chen H#, Acupuncture for de Quervain's tenosynovitis: a randomized controlled trial, Phytomedicine,2022,154254, doi: 10.1016/j.phymed.2022.154254.
2. Chen HY*, Yeung WF#, Yang MX, Mu JL, Ziea T, Ng BFL, Lao L#. Guideline Acupuncture for low back pain: a clinical practice guideline from the Hong Kong taskforce of standardized acupuncture practice. J Tradit Chin Med. 2022 Feb;42(1):140-147. PMID: 35294134.
3. Jin J, Chen H#, Meng XM#. Editorial: Epigenetic Regulation in Renal Development, Physiology and Disease. Front Physiol. 2022 Jan 5;12:818190. doi: 10.3389/fphys.2021.818190. PMID: 35069267; PMCID: PMC8766424.
4. Wang YF, Chen H#. Ferroptosis in Diabetic Nephropathy: A Narrative Review. Integr Med Nephrol Androl 2022;9:1.
5. Guo J, Qin Z, Lau NC, Fong TL, Meng W, Zhang ZJ, Luo Y, Wong VCT, Feng Y, Chen H#. Chinese Medicine for Coronavirus Disease 2019 (COVID-19): A GRADE-Assessed Systematic Review and Meta-Analysis. Am J Chin Med. 2021 Dec 2:1-31. doi: 10.1142/S0192415X2250001X.
6. Guo J*, Qin Z*, He Q*, Fong TL, Lau NC, Cho WCS, Zhang H, Meng P, Xing X, Li M, Zhang ZJ#, Chen H#. Shexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress. Oxid Med Cell Longev. 2021 Nov 30;2021:7644648. doi: 10.1155/2021/7644648. PMID: 34900089; PMCID: PMC8652282.
7. Wu W, Wang Y, Li HD, Chen H#, Shen JG#. Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF-β/Smad3 signaling-mediated renal fibrosis and inflammation. Chin Med. 2021 Nov 14;16(1):118. doi: 10.1186/s13020-021-00531-1.
8. Ning Z, Gu P, Zhang J, Cheung CW, Lao L, Chen H#, Zhang ZJ#. Adiponectin regulates electroacupuncture-produced analgesic effects in association with a crosstalk between the peripheral circulation and the spinal cord. Brain Behav Immun. 2021 Sep 22;99:43-52. doi: 10.1016/j.bbi.2021.09.010. Epub ahead of print. PMID: 34562596.
9. You YK, Wu WF, Huang XR, Li HD, Ren YP, Zeng JC, Chen H#, Lan HY#. Deletion of Smad3 protects against C-reactive protein-induced renal fibrosis and inflammation in obstructive nephropathy. Int J Biol Sci. 2021 Sep 21;17(14):3911-3922. doi: 10.7150/ijbs.62929. PMID: 34671208; PMCID: PMC8495386.
10. Wu WF, Huang XR, You Y, Xue L, Wang XJ, Meng XM, Lin X, Shen J, Yu X, Lan HY#, Chen HY#. Latent TGF-β1 protects against diabetic kidney disease via Arkadia/Smad7 signaling. Int J Biol Sci. 2021 Aug 19;17(13):3583-3594. doi: 10.7150/ijbs.61647. PMID: 34512167; PMCID: PMC8416717.
11. Wong YK*, Wu JM*, Zhou G, Zhu F, Zhang Q, Yang XJ, Qin Z, Zhao N, Chen HY#, Zhang ZJ#. Antidepressant Monotherapy and Combination Therapy with Acupuncture in Depressed Patients: A Resting-State Functional Near-Infrared Spectroscopy (fNIRS) Study. Neurotherapeutics. 2021 Oct;18(4):2651-2663. doi: 10.1007/s13311-021-01098-3. Epub 2021 Aug 24. PMID: 34431029.
12. Lam WC, Au KY, Qin Z, Wu FM, Chong CO, Jiang F, He Y, Ng BFL, Yeung WF, Lao L, Chen HY#. Superficial Needling Acupuncture vs Sham Acupuncture for Knee Osteoarthritis: A Randomized Controlled Trial. Am J Med. 2021 Jun 11:S0002-9343(21)00320-X. doi: 10.1016/j.amjmed.2021.05.002. Epub ahead of print. PMID: 34126097.
13. Chen HY#, So TH, Cho WC, Qin Z, Ma CH, Li SG, Yang Z, Jiang F, Wu J, Zhang ZJ, Kong FM, Lao L. The Adjunctive Effect of Acupuncture for Advanced Cancer Patients in a Collaborative Model of Palliative Care: Study Protocol for a 3-Arm Randomized Trial. Integr Cancer Ther. 2021 Jan - Dec; 20 :15347354211012749. doi: 10.1177/15347354211012749. PMID: 33957783.
14. Shao BY*, Zhang SF*, Li HD, Meng XM#,  Chen HY#. Epigenetics and Inflammation in Diabetic Nephropathy. Front. Physiol., 2021 May 05; 12: 649587. https://doi.org/10.3389/fphys.2021.649587.
15. Sin SH, Wu J, Kang Y, Yip KHK, Kong NS, Wan H, Ng BFL, Chen H#. Efficacy of modified Banxia Xiexin decoction in the management of Wei-Pi syndrome (postprandial distress syndrome): study protocol for a randomized, waitlist-controlled trial. Trials. 2021 Feb 12;22(1):135. doi: 10.1186/s13063-021-05078-y.
16. Yu JT*, Hu XW*, Chen HY*, Yang Q, Li HD, Dong YH, Zhang Y, Wang JN, Jin J, Wu YG, Li J, Ge JF, Meng XM. DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-α in alcohol-induced kidney injury. Pharmacological Research. 2020 Nov:105286. DOI: 10.1016/j.phrs.2020.105286.
17. Chen Y, Xiang XY, Chin KHR, Gao J, Wu J, Lao L, Chen HY#. Acupressure for labor pain management: A systematic review and meta-analysis of randomized controlled trials. Acupuncture in Medicine. 2020 Aug 18;964528420946044.doi: 10.1177/0964528420946044
18. Chen HY*, Wang C*, Zhou MJ, Chan PY, Yam LL, Lam WL, Leung KP, Li SW, Tsang WY, Ng BFL, Ziea ETC, Yeung WF, Lao L. Electroacupuncture on Post-Stroke Overactive Bladder: A Multi-site Pilot Randomized Controlled Trial. Acupuncture in Medicine 2020 Jul 9;964528420925488. doi: 10.1177/0964528420925488
19. Wu WF*, Wang JN*, Lia Z*, Wei B, Jin J, Gao L, Li HD, Li J, Chen HY#, Meng XM#. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation. Phytomedicine.2020 Mar 2;69:153202. doi: 10.1016/j.phymed.2020.153202.
20. Yang Q*, Chen HY*, Wang JN*, Han HQ, Jiang L, Wu WF,  Wei B, Gao L, Ma QY, Liu XQ, Chen Q, Wen JG, Jin J, Huang Y, Ni WJ, Ma TT, Li J, Meng XM. Alcohol promotes renal fibrosis by activating Nox2/4-mediated DNA methylation of Smad7. Clin Sci (Lond). 2020 Jan 31;134(2):103-122. doi: 10.1042/CS20191047.
21. You YK*, Luo Q*, Wu WF, Zhang JJ, Zhu HJ, Lao L, Lan HY, Chen HY#, Cheng YX#. Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling. J Cell Mol Med. 2019 Aug;23(8):5576-5587. doi: 10.1111/jcmm.14454. Epub 2019 Jun 18.
22. Chen HY, Liu NY. Analgesic Effect of Sinew Acupuncture for Patients with Soft-Tissue Injuries: A Pilot Trial. Chin J Integr Med., 2019 Aug;25(8):613-616. doi: 10.1007/s11655-019-3061-3. Epub 2019 Jan 18.
23. Chen HY, Yang MX, Ning ZP,  Lam WL, Zhao YK, Yeung WF, Ng LBF, Ziea ETC, Lao L. A Guideline for Randomized Controlled Trials of Acupuncture. Am J Chin Med. 2019;47(1):1-18. doi: 10.1142/S0192415X19500010.
24. Chen HY, Yang MX, Lao L. Acupuncture for Women Undergoing In Vitro Fertilization (Letter to editor). JAMA-Journal of the American Medical Association. 2018 Oct 2;320(13):1385. doi: 10.1001/jama.2018.10538.
25. Cho CSW. Cui L. Chen HY#. Clinical efficacy of acupoint embedment in weight control: a systematic review and meta-analysis. Medicine (Baltimore). 2018 Sep;97(36):e12267. doi: 10.1097/MD.0000000000012267.
26. Au KY, Chen HY#, Lam WC, Chong CO, Lau A, Vardhanabhuti V, Mak KC, Jiang F, Lam WY, Wu FM, Chan HN, Ng YW, Ng BF, Ziea ET, Lao L. Sinew acupuncture for knee osteoarthritis: study protocol for a randomized sham-controlled trial. BMC Complement Altern Med. 2018 Apr 23;18(1):133. doi: 10.1186/s12906-018-2195-8.
27. Zhong X, Tu YJ, Li Y, Zhang P, Wang W, Chen SS, Li L, Chung AC, Lan HY, Chen HY#, Li GS#, Wang L#. Serum levels of WNT1-inducible signaling pathway protein-1 (WISP-1): a noninvasive biomarker of renal fibrosis in subjects with chronic kidney disease. Am J Transl Res 2017;9(6):2920-2932.
28. Chen HY, Ning Z, Lam WL, Lam WY, Zhao YK, Yeung YF, Ng BFL, Ziea ETC, Lao L. Types of Control in acupuncture clinical trials might affect the conclusion of the trials: a review of acupuncture on pain management. JAMS. 2016 Oct;9(5):227-233. doi: 10.1016/j.jams.2016.08.001
29. Chen HY, Lan HY, Roukos DH, Cho WC. Application of microRNAs in diabetes mellitus. J Endocrinol. 2014 Jul; 222(1):R1-R10. doi: 10.1530/JOE-13-0544  
30. Chen HY, Feng Y, Lao L. Chinese integrative medicine: inclusion of a Chinese medicine programme in a conventional medical institute. J Integr Med. 2014 May;12(3):187-90. doi: 10.1016/S2095-4964(14)60027-3.
31. Chen HY, Zhong X, Huang XR, Meng XM, Chung ACK, Lan HY. MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice. Molecular Therapy,2014 Apr;22(4):842-53. doi: 10.1038/mt.2013.235.
32. Chen HY, Ma CH, Cao KJ, Ho JCM, Ziea E, Wong VT, Zhang ZJ. A Systematic Review and Meta-Analysis of Herbal Medicine on Chronic Obstructive Pulmonary Diseases. Evidence-Based Complementary and Alternative Medicine, 2014, 11. doi: 10.1155/2014/925069.
33. Chen HY, Li SG, Cho WCS, Zhang ZJ. The Role of Acupoint Stimulation as an Adjunct Therapy for Lung Cancer: a Systematic Review and Meta-analysis. BMC Complementary and Alternative Medicine2013 Dec;13:362.doi:10.1186/1472-6882-13-362.
34. Li SG*, Chen HY*, Ou-Yang CS, Wang XX, Yang ZJ, Tong Y, Cho WC. The Efficacy of Chinese Herbal Medicine as an Adjunctive Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis. PLOS One. 2013;8(2):e57604. doi: 10.1371/journal.pone.0057604.
35. Zhong LD*, Chen HY*, Cho WCS, Meng XM, Tong Y. The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis. Complementary Therapies in Medicine. 2012 March 3. doi:10.1016 /j.ctim.2012.02.004.
36. Chen HY, Huang XR, Wang W, Li JH, Heuchel RL, Chung AC, Lan HY. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes. 2011 Feb;60(2):590-601.
37. Liu Fei*, Chen HY*, Huang Xiao R, Chung Arthur CK, Zhou Li, Fu Ping, Szalai A. J., LanHui Yao. C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes. Diabetologia. 2011 54(10):2713-2723.
38. Cho WCS*, Chen HY*. Clinical Efficacy of Traditional Chinese Medicine as a Concomitant Therapy for Nasopharyngeal Carcinoma: A Systemic Review and Meta-Analysis. Cancer Invest. 2009; 27:334-344.
39. Chen HY, Sze SCW, Tong Y. Treatment of menopausal symptoms with Er-xian decoction: a systematic review. Am. J. Chin. Med. 2008;36(2):233-44.
40. Chen HY, Shi Y, Ng CS, Chan SM, Yung KK, Zhang QL. Auricular acupuncture treatment for insomnia: a systematic review. J Altern Complement Med. 2007 Jul-Aug;13(6):669-76.

As co-authors

41. Wang JN, Wang F, Ke J, Li Z, Xu CH, Yang Q, Chen X, He XY, He Y, Suo XG, Li C, Yu JT, Jiang L, Ni WJ, Jin J, Liu MM, Shao W, Yang C, Gong Q, Chen HY, Li J, Wu YG, Meng XM. Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms. Sci Transl Med. 2022 Apr 13;14(640):eabk2709. doi: 10.1126/scitranslmed.abk2709. Epub 2022 Apr 13. PMID: 35417191.
42. Tang PM, Chen HY, Tang Y, Nikolic-Paterson DJ, Lan HY. Editorial: Immune Landscape of Kidney Pathology. Front Physiol. 2022 Jan 25;12:827537. doi: 10.3389/fphys.2021.827537. PMID: 35145431; PMCID: PMC8822390.
43. Wang N, Zhang C, Xu Y, Tan HY, Chen H, Feng Y. Berberine improves insulin-induced diabetic retinopathy through exclusively suppressing Akt/mTOR-mediated HIF-1α/VEGF activation in retina endothelial cells. Int J Biol Sci. 2021 Oct 20;17(15):4316-4326. doi: 10.7150/ijbs.62868. PMID: 34803500; PMCID: PMC8579442.
44. Chan KW, Chen HY, Feng YB, Wong VT. The use of integrative medicine for treatment of COVID-19. The Hong Kong Medical Diary. 2021; 26(6), 15-19.
45. Zhang J, Yang M, So TH, Chang TY, Qin Z, Chen H, Lam WL, Yeung WF, Chung KF, Jiang F, Lao L, Zhang ZJ. Electroacupuncture Plus Auricular Acupressure on Chemotherapy-Related Insomnia in Patients With Breast Cancer (EACRI): Study Protocol for a Randomized, Sham-Controlled Trial. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211058695. doi: 10.1177/15347354211058695. PMID: 34802291; PMCID: PMC8606933.
46. Tang G, Li S, Zhang C, Chen HY, Wang N, Feng Y. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Acta Pharm Sin B. 2021 Sep;11(9):2749-2767. doi: 10.1016/j.apsb.2020.12.020. Epub 2021 Feb 2. PMID: 34589395; PMCID: PMC8463270.
47. Wang L, Liu F, Li J, Ma L, Feng H, Liu Q, Cho WC, Chen HY, Chen H, Guo H, Li Z, Howard SC, Li M, Shan B, Gu W, Ji J. From Anti-PD-1/PD-L1 to CTLA-4 and to MUC1-Is the Better Response to Treatment in Smokers of Cancer Patients Drug Specific? J Pers Med. 2021 Sep 13;11(9):914. doi: 10.3390/jpm11090914. PMID: 34575691; PMCID: PMC8471889.
48. Zhang J, Qin Z, So TH, Chen HY, Lam WL, Yam LL, Yan Chan P, Lao L, Zhang ZJ. Electroacupuncture Plus Auricular Acupressure for Chemotherapy-Associated Insomnia in Breast Cancer Patients: A Pilot Randomized Controlled Trial. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211019103. doi: 10.1177/15347354211019103. PMID: 34036813; PMCID: PMC8161840.
49. Li S, Cheng CS, Zhang C, Tang GY, Tan HY, Chen HY, Wang N, Lai AY, Feng Y. Edible and Herbal Plants for the Prevention and Management of COVID-19. Front Pharmacol. 2021 Apr 28;12:656103. doi: 10.3389/fphar.2021.656103. PMID: 33995078; PMCID: PMC8113769.
50. Zhang S, Chen HY, Shao B, Lao L. Effect of Herbs on Postoperative Intestinal Obstruction: A Case Report. Altern Ther Health Med. 2021 Apr 23:AT6813. Epub ahead of print. PMID: 33891567.
51. Huang M, Zhang W, Chen HY, Zeng J. Targeting Polyamine Metabolism for Control of Human Viral Diseases. Infect Drug Resist. 2020 Dec 1;13:4335-4346. doi: 10.2147/IDR.S262024. (IF: 2.984)
52. Wang JN, Yang Q, Yang C, Cai YT, Xing T, Gao L, Wang F, Chen X, Liu XQ, He XY, Wei B, Jiang L, Li C, Jin J, Wen JG, Ma TT, Chen HY, Li J, Meng XM.Smad3 promotes AKI sensitivity in diabetic mice via interaction with p53 and induction of NOX4-dependent ROS production. Redox Biol. 2020 Feb 26;32:101479. doi: 10.1016/j.redox.2020.101479. (IF: 7.793, 28/298 in Biochemistry&molecular biology)
53. Li Y, Yang M, Wu F, Cheng K, Chen HY, Shen X, Lao L. Mechanism of electroacupuncture on inflammatory pain: neural-immune-endocrine interactions. J Tradit Chin Med. 2019 Oct;39(5):740-749. (IF:0.907, 23/27 in Integrative&Complementary Medicine)
54. Mak TC, Chen HY, Cho WC. Acupuncture for overactive bladder in adults: a systematic review and meta-analysis. Acupunct Med. 2019 Aug 21:acupmed2017011528. doi: 10.1136/acupmed-2017-011528. (IF: 2.637, 6/27 in Integrative&Complementary Medicine)
55. Cheung DST, Yeung WF, Suen LK, Chong TC, Ho YS, Yu BY, Chan LY, Chen HY, Lao L.Self-administered acupressure for knee osteoarthritis in middle-aged and older adults: a pilot randomized controlled trial. Acupunct Med. 2019 Nov 13:964528419883269. doi: 10.1177/0964528419883269. (IF: 2.637, 6/27 in Integrative&Complementary Medicine)
56. Ying J, Zhou M, Chen HY, Chen L, Zhang W, Ji J, Chao Yu, Zhang ZJ. A Double-blind, Randomized Controlled Trial of Essential Oil for Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Chinese Journal of Integrative Medicine, 2018 Jun 8. doi: 10.1007/s11655-018-2797-5. (IF: 1.445, 17/27 in Integrative&Complementary Medicine)
57. Liu JY, Chen XX, Chen HY, Shi J, Leung GP, Tang SC, Lao LX, Yip HK, Lee KF,Sze SC, Zhang ZJ, Zhang KY. Downregulation of Aquaporin 9 Exacerbates Beta-amyloid-induced Neurotoxicity in Alzheimer's Disease Models In vitro and In vivo. Neuroscience. 2018 Dec 1;394:72-82. doi:10.1016/j.neuroscience.2018.09.016. Epub 2018 Sep 26. PubMed PMID: 30266683.( IF: 3.24,  114/267 in Neurosciences)
58. Song TH, Chen X, Lee CKF, Sze SCW, Feng YB, Yang ZJ, Chen HY, Li ST, Zhang LY, Wei G, Shi J, Xua K, Ng TB, Zhu LL, Zhang KYB. Dendrobine targeting JNK stress signaling to sensitize chemotoxicity of cisplatin against non-small cell lung cancer cells in vitro and in vivo. Phytomedicine. 2019; 53:18-27, doi:10.1016/j.phymed.2018.06.018. (IF: 4.180, 1/27 in Integrative&Complementary Medicine)
59. Lee E, Xie Y, Chen H, Meng W. Systematic Review of Chinese Medicine for Ovarian Endometriosis. International Journal of Pharmacognosy and Chinese Medicine.2017; 1(3): 1-8. (no impact factor)
60. Lam WL, Yeung WF, Wong MK, Cheung CW, Chan KKL, Ngan HYS, Wong CKH, Chen HY, Lao L. Combined electroacupuncture and auricular acupuncture for postoperative pain after abdominal surgery for gynecological diseases: study protocol for a randomized controlled trial. Trials. 2018 Jan 4;19(1):8. doi: 10.1186/s13063-017-2359-8. (IF: 1.975,  96/136 in Research & Experimental Medicine)
61. Chan LK, Ganotice F Jr, Wong FKY, Lau CS, Bridges SM, Chan CHY, Chan N, Chan PWL, Chen HY, Chen JY, Chu JKP, Ho CC, Ho JMC, Lam TP, Lam VSF, Li Q, Shen JG, Tanner JA, Tso WWY, Wong AKC, Wong GTC, Wong JYH, Wong NS, Worsley A, Yu LK, Yum TP. Implementation of an interprofessional team-based learning program involving seven undergraduate health and social care programs from two universities, and students' evaluation of their readiness for interprofessional learning. BMC Med Educ. 2017 Nov 21;17(1):221. doi: 10.1186/s12909-017-1046-5. (IF: 1.870, 79/243 in Eudcation&Educational Research)
62. Liu Z, Huang XR, Chen HY, Fung Erik, Liu J, Lan HY. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation. Hypertension. 2017 Oct; 70(4):822-830. doi: 10.1161/HYPERTENSIONAHA.117.09600. (IF: 7.017,  13/201 in Peripheral Vascular Disease)
63. Yeung WF, Ho  Fiona YY, Chung KF, Yu Branda YM, Suen Lorna, Chan YT, Chen HY, Ho LM, Lao L. Self-administered Acupressure for Insomnia Disorder: A Pilot Randomised Controlled Trial. Journal of Sleep Research, 2017 Sep 8. doi: 10.1111/jsr.12597. (IF: 3.432,  61/199 in Clinical Neurology )
64. Wei W, Chen HY, Fan W, Ye SF, Xu YH, Cai J. Chinese medicine for idiopathic Parkinson's disease: A meta analysis of randomized controlled trials. Chinese Journal of Integrative Medicine. 2017 Jan;23(1):55-61. doi: 10.1007/s11655-016-2618-7. (IF: 1.445, 17/27 in Integrative&Complementary Medicine)
65. You YK, Huang XR, Chen HY, Lyu XF, Liu HF, Lan HY. C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway. Sci Rep. 2016 May 25;6:26740. doi: 10.1038/srep26740. (IF: 4.011, 15/69 in Multidisciplinary Sciences)
66. Huang L, You YK, Zhu TY, Zheng LZ, Huang XR, Chen HY, Yao D, Lan HY, Qin L. Validity of leptin receptor-deficiency (db/db) type 2 diabetes mellitus mice as a model of secondary osteoporosis. Sci Rep. 2016 Jun 10;6:27745. doi: 10.1038/srep27745. (IF: 4.011, 15/69 in Multidisciplinary Sciences)
67. Wang J, Chu ES, Chen HY, Man K, Go MY, Huang XR, Lan HY, Sung JJ, Yu J. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget. 2015 Mar 30;6(9):7325-38. PMID: 25356754. (IF: 5.008 in 2015, no impact factor now)
68. Zhao BX, Chen HY, Shen XY, Lao L. Can moxibustion, an ancient treatment modality, be evaluated in a double-blind randomized controlled trial? - A narrative review. J Integr Med. 2014 May;12(3):131-134. doi: 10.1016/S2095-4964(14)60024-8. (no impact factor)
69. Liu GX, Li YQ, Huang XR, Wei LH, Zhang Y, Feng M, Meng XM, Chen HY, Shi YJ, Lan HY.Smad7 inhibits Ang II-mediated hypertensive nephropathy in a mouse model of hypertension.Clin Sci (Lond). 2014 Aug;127(3):195-208. doi: 10.1042/CS20130706. (IF: 5.237, 19/136 in Research & Experimental Medicine)
70. Wei LH, Huang XR, Zhang Y, Li YQ, Chen HY, Yan BP, Yu CM, Lan HY.Smad7 Inhibits Angiotensin II-induced Hypertensive Cardiac Remodeling. Cardiovasc Res. 2013;99(4):665-73. doi: 10.1093/cvr/cvt151. (IF: 7.014,  12/136 in Cardiac&Cardiovasuclar Systems)
71. Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, Yang W, Hou FF, Lan HY. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia. 2013 Mar;56(3):663-74. doi: 10.1007/s00125-012-2804-x. (IF: 7.113, 12/145 in Endocrinology&Metabolism)
72. Wei LH, Huang XR, Zhang Y, Li YQ, Chen HY, Heuchel R, Yan BP, Yu CM, Lan HY. Deficiency of Smad7 Enhances Cardiac Remodeling Induced by Angiotensin II Infusion in a Mouse Model of Hypertension. PLoS One. 2013; 8(7):e70195. doi: 10.1371/ journal.pone.0070195. (IF: 2.776, 24/69 in Multidesciplinary Sciences)
73. Liu GX, Li YQ, Huang XR, Wei LH,  Chen HY, Shi YJ, Heuchel Rainer L, Lan HY. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/Smad3-NF.kappaB-dependent mechanisms in mice. PLoS One. 2013;8(1): e53573. doi: 10.1371/journal.pone.0053573. (IF: 2.776, 24/69 in Multidesciplinary Sciences)
74. Meng XM, Huang XR, Xiao J, Chen HY, Zhong X, Chung AC, Lan HY. Diverse roles of TGF-ß receptor II in renal fibrosis and inflammation in vivo and in vitro. J Pathol. 2012 Jun; 227 (2):175-88. doi: 10.1002/path.3976. (IF: 5.942, 8/76 in Pathology)
75. Meng XM, Huang XR, Xiao J, Chung AC, Qin W, Chen HY, Lan HY. Disruption of Smad4 impairs TGF-ß/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int. 2012 Feb;81(3):266-79. doi: 10.1038/ki.2011.327. (IF: 8.306,  5/80 in Urology&Nephrology)
76. Liu Z, Huang XR, Chen HY, Penninger JM, Lan HY. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy. Lab Invest. 2012 Feb 13. doi: 10.1038/labinvest.2012.2. (IF: 3.684, 49/136 in Research&Experimental Medicine)
77. Zhong Xiang, Chung ACK, Chen HY, Meng Xiao Ming, LanHui Yao. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. Journal of the American Society of Nephrology. 2011 Sep 22(9):1668-81. (IF: 8.547, 4/80 in Urology&Nephrology)
78. Zhou L, Liu F, Huang XR, Liu F, Chen HY, Chung AC, Shi J, Wei L, Lan HY, Fu P. Amelioration of Albuminuria in ROCK1 Knockout Mice with Streptozotocin-Induced Diabetic Kidney Disease. Am J Nephrol. 2011 Oct 4;34(5):468-475. (IF: 2.961, 20/80 in Urology&Nephrology)
79. Zhang ZJ, Chen HY, Yip KC, Ng R, Wong VT. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord. 2010 Jul;124(1-2):9-21. (IF: 4.084, 21/142 in Psychiatry)
80. Cho WCS, Chen HY. Transcatheter arterial chemoembolization combined with or without Chinese herbal therapy for hepatocellular carcinoma: meta-analysis. Expert Opinion On Investigational Drugs. 2009;18(5):617-35. (IF: 4.031,  51/267 in Pharmacology&Pharmacy)

PUBLICATIONS (In Chinese)

81. 林麗群，陳海勇*，針灸治療糖尿病胃輕癱的療效評價.香港中醫藥雜誌, 2021,16(1):54-58
82. 葉俊宏, 溫 熙, 林嘉豪, 張俊曦, 廖冠雄, 文曦兒, 劉明藝, 黃曆恒, 朱南孫, 李啟輝, 張艶波, 石軍, 趙佳, 陳海勇, 張樟進, 勞力行, 孟煒. 中醫臨床專方治療子宮內膜異位症型痛經及相關實驗研究分析. 中醫學. 2019, 8(4):254-261.
83. 陈海勇，黄飞霞，裴霞，陆怡衡，周立群，孙灵芝，甄雪燕，宋佳，赵艳，劳力行.胡焕章名老中医处方用药的“经权”观念.中医杂志.（稿号：20175426-10，2017年11月接收）
84. 陆怡衡,裴霞,陈海勇,黄飞霞,周立群,孙灵芝,甄雪燕,宋佳,赵艳,劳力行.胡焕章教授“气血病机的临床思维”[J].环球中医药,2018(04):554-556.
85. 宋佳,孫靈芝,甄雪燕,趙艶,鄭越,勞力行,陳海勇,裴霞,陸怡衡,黃飛霞,周立群. 論外感與內傷的統一性[J]. 新中醫,2017,49(07):174-177.
86. 黃飛霞，陳海勇，裴霞，陸怡衡，周立群，勞力行，宋佳，孫靈芝，甄雪燕，趙艷，鄭越. 胡煥章運用“知常達變”治療脾胃病經驗[J]. 河北中醫，2017，(06):805-808+818.
87. 甄雪燕，周立群，宋佳，孫靈芝，趙艷，鄭越，勞力行，陳海勇，裴霞，陸怡衡，黃飛霞. 胡煥章教授談“和法”[J]. 時珍國醫國藥，2016，(11):2760-2761.
88. 孫靈芝，宋佳，甄雪燕，趙艷，鄭越，勞力行，陳海勇，裴霞，陸怡衡，黃飛霞，周立群. 全國名老中醫胡煥章對中西醫學互補理論的闡釋[J]. 世界中西醫結合雜誌，2016，(12):1645-1649.
89. 張曉雨，寧志鵬，陳海勇，勞力行. 針刺治療膝骨性關節炎的臨床試驗結果與對照組設置相關性研究的系統分析. 中國疼痛醫學雜志， 2015，21(10):732-737
90. 李秀珍，陳海勇，鄭驍，劉農虞. 针刺配合牵引治疗腰椎间盘突出症的系统评价.中國針灸 [Acupuncture combined with traction therapy for lumbar disc herniation: a systematic review].[Article in Chinese] Zhongguo Zhen Jiu. 2014 Sep;34(9):933-40. PMID: 25509761
91. 楊頴輝, 陳海勇, 鍾家輝, 張樟進. 傳統中醫療法治療失眠的臨床試驗——現狀與展望.世界睡眠醫學雜誌, 2014, 1(1):54-58
92. 陳海勇.仲景運用大黃配伍規律之探討. 中醫藥實證醫學雜誌,2013,6(1):39-46
93. 童瑤，陳海勇.中醫臨床研究的現狀與展望.中醫藥實證醫學雜誌，2009，2(1):22-30
94. 陳海勇，童瑤.試論張仲景運用細辛的規律.上海中醫藥大學學報. 2007，21(3):12-14
95. 應薦，陳海勇，徐福松. 補腎滋陰法對腎上腺皮質激素型腎陰虛大鼠睾丸組織超微結構的影響. 中西醫結合學報，2006，4(6):620-623.
96. 陳海勇，房偉略. 《傷寒論》探"煩". 江蘇中醫藥, 2005,26(6): 7-8
97. 陳海勇.《傷寒論》下利探析.《中醫雜誌》增刊. 2005年

BOOKS AND CHAPTERS

98. Chen HY, Yao Tong. Chapter 1 Systematic Reviews and Meta-analyses. Professional English for Research in Traditional Chinese Medicine. People’s Medical Publishing House. In press
99. Lixing Lao, Chen HY. Chapter 6 How to Design, Conduct and Report a Randomized Controlled Trial (RCT) on Acupuncture. Professional English for Research in Traditional Chinese Medicine. People’s Medical Publishing House. In press
100. 張樟進, 楊頴輝,陳海勇.第11章 中药精神药理和临床应用.《精神药理学》刘吉成,艾静主編（第2版）（十三五规划教材）.北京:人民卫生出版社.2016年11月.Pp247-261
101. Chen HY, Lixing Lao. Chapter 13 Challenges in Evaluating Acupuncture Trials. Acupuncture in Pain Management.(Editor, Lucy Chen; ISBN: 978-1-63463-047-4). New York: Nova Science Publishers,Inc.2014.4th Quarter.Pp163-172
102. 張樟進,陳海勇.第21章 强迫症.《中醫情志病學》.曲麗芳,張葦航主編.上海:上海科學技術出版社.2015年1月.Pp213-218
103. 張樟進,陳海勇.第5章 狂病.《中醫情志病學》.曲麗芳,張葦航主編.上海:上海科學技術出版社.2015年1月.Pp70-75
104. 藍輝耀，陳海勇. 第30章TGF-β/Smad系統與腎臟炎癥和纖維化調節.《生理科學進展》.王建军、王晓民主编（字数：1300千字；全书798页；ISBN： 978-7-04-039835-9）. 北京:高等教育出版社.2014. Pp448-462